SCHEMBL8949346

SCHEMBL8949346

Cc1cnc(Cc2ccccc2)n1CCCNCc1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
CHRM2 P08172 2/20 0.43
POLB P06746 1/20 0.41
BCHE P06276 1/20 0.41
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 2/20 0.40
THRB P10828 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAOA P21397 1/20 0.39
SCN8A Q9UQD0 1/20 0.39
HRH4 Q9H3N8 2/20 0.38
HRH3 Q9Y5N1 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443498 0.84 TMEM97 (0.45) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB
SCHEMBL8949377 0.81 HTR1A (0.43) SMN1; SMN2CHRM2LMNASCN8A
SCHEMBL14416025 0.79 MAOA (0.49) SIGMAR1CHRM2TDP1MAOASCN8A
SCHEMBL8949671 0.77 SIGMAR1 (0.46) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB
SCHEMBL8445852 0.76 SMN1; SMN2 (0.42) SIGMAR1SMN1; SMN2LMNATP53KDM4E
SCHEMBL8445940 0.69 CHRM2 (0.50) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB
SCHEMBL9523328 0.68 SIGMAR1 (0.70) TMEM97SIGMAR1SMN1; SMN2CHRM2BCHE
SCHEMBL8444335 0.68 TMEM97 (0.45) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB
SCHEMBL8443179 0.67 ALDH1A1 (0.50) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB
SCHEMBL8445814 0.67 CHRM2 (0.50) TMEM97SIGMAR1SMN1; SMN2CHRM2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5547972-A 1-(ARLALKYLAMINOALKYL) IMIDAZOLE DERIVATIVES THE BOOTS COMPANY PLC (GB) 1996-08-20 US disclosed
WO-1995022327-A1 USE OF 1-(ARYLALKYLAMINOALKYL) IMIDAZOLES FOR TREATING NEUROLOGICAL DAMAGE KNOLL AG (DE) 1995-08-24 WO disclosed
EP-0618907-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS Knoll AG (DE) 1994-10-12 EP disclosed
WO-1993013075-A1 1-(ARYLALKYL-AMINOALKYL)IMIDAZOLE DERIVATIVES, PROCESSES OF PREPARATION AND USE AS THERAPEUTICAL AGENTS THE BOOTS COMPANY PLC (GB) 1993-07-08 WO disclosed